GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » Additional Paid-In Capital

Genetic Analysis AS (XSAT:GEAN.TO.2) Additional Paid-In Capital : kr5.95 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Additional Paid-In Capital?


Genetic Analysis AS's quarterly additional paid-in capital stayed the same from Jun. 2023 (kr29.19 Mil) to Sep. 2023 (kr29.19 Mil) and stayed the same from Sep. 2023 (kr29.19 Mil) to Dec. 2023 (kr5.95 Mil).

Genetic Analysis AS's annual additional paid-in capital declined from Dec. 2021 (kr57.14 Mil) to Dec. 2022 (kr29.19 Mil) and declined from Dec. 2022 (kr29.19 Mil) to Dec. 2023 (kr5.95 Mil).

Genetic Analysis AS Additional Paid-In Capital Historical Data

The historical data trend for Genetic Analysis AS's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Additional Paid-In Capital Chart

Genetic Analysis AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
147.75 36.32 57.14 29.19 5.95

Genetic Analysis AS Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.19 29.19 29.19 29.19 5.95

Genetic Analysis AS Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Genetic Analysis AS Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (XSAT:GEAN.TO.2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN.TO.2) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:IMMNOV XSAT:SPERM OSTO:PROGEN XSAT:CALMA B XSAT:ALPH NGM:ATANA TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS
Traded in Other Exchanges
GEAN:Sweden
Address
Kabelgata 8, Oslo, NOR, 0580
Website
https://www.genetic-analysis.com
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (XSAT:GEAN.TO.2) Headlines

No Headlines